How does bone marrow transplantation affect ovarian function and fertility?

被引:46
作者
Jadoul, Pascale [1 ]
Donnez, Jacques [1 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Gynecol, Inst Rech Expt & Clin,Unite Rech GYNE, B-1200 Brussels, Belgium
关键词
bone marrow transplantation; conditioning regimen; fertility preservation; gonadal damage; TOTAL-BODY IRRADIATION; ANTI-MULLERIAN HORMONE; STEM-CELL TRANSPLANTATION; IN-VITRO MATURATION; MONOZYGOTIC TWINS DISCORDANT; ACUTE LYMPHOBLASTIC-LEUKEMIA; PRE-ANTRAL FOLLICLES; HIGH-DOSE BUSULFAN; GONADAL-FUNCTION; YOUNG-WOMEN;
D O I
10.1097/GCO.0b013e328353bb57
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review This article sets out to review the literature on gonadal toxicity of bone marrow transplantation (BMT) in women, and preventive and curative actions available for girls and women facing BMT and infertility. Findings The real incidence of ovarian damage after BMT is difficult to assess. Series reporting ovarian function and pregnancies after BMT vary greatly in terms of endpoints, number of patients included, age at and indications for BMT, conditioning regimens and duration of follow-up. The risk of premature ovarian failure (POF) is very high, however, and increases with age and in case of BMT conditioning treatment with total body irradiation. Embryo, oocyte and ovarian cortex cryopreservation are effective fertility preservation methods that should be discussed with all girls and young women requiring BMT. Summary Despite a lack of literature on long-term follow-up of fertility after BMT in large populations, it is clear that the risk of ovarian damage and POF is very high. Fertility preservation options should therefore be discussed with all patients having to undergo BMT.
引用
收藏
页码:164 / 171
页数:8
相关论文
共 83 条
[1]   Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix [J].
Amorim, Christiani A. ;
Van Langendonckt, Anne ;
David, Anu ;
Dolmans, Marie-Madeleine ;
Donnez, Jacques .
HUMAN REPRODUCTION, 2009, 24 (01) :92-99
[2]   The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer [J].
Anderson, R. A. ;
Themmen, A. P. N. ;
Al-Qahtani, A. ;
Groome, N. P. ;
Cameron, D. A. .
HUMAN REPRODUCTION, 2006, 21 (10) :2583-2592
[3]   Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients [J].
Ata, Baris ;
Chian, Ri-Cheng ;
Tan, Seang Lin .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2010, 24 (01) :101-112
[4]   RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study (Retracted article. See vol. 120, pg. 395, 2023) [J].
Badawy, Ahmed ;
Elnashar, Aboubakr ;
El-Ashry, Mohamed ;
Shahat, May .
FERTILITY AND STERILITY, 2009, 91 (03) :694-697
[5]   Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies [J].
Bakker, B ;
Massa, GG ;
Oostdijk, W ;
Van Weel-Sipman, MH ;
Vossen, JM ;
Wit, JM .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (1-2) :31-37
[6]   Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound [J].
Bath, LE ;
Wallace, WHB ;
Shaw, MP ;
Fitzpatrick, C ;
Anderson, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2368-2374
[7]  
Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1016/S1470-0328(02)01007-8
[8]   Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis [J].
Bedaiwy, Mohamed A. ;
Abou-Setta, Ahmed M. ;
Desai, Nina ;
Hurd, William ;
Starks, David ;
El-Nashar, Sherif A. ;
Al-Inany, Hesham G. ;
Falcone, Tommaso .
FERTILITY AND STERILITY, 2011, 95 (03) :906-U94
[9]   No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group [J].
Behringer, K. ;
Wildt, L. ;
Mueller, H. ;
Mattle, V. ;
Ganitis, P. ;
van den Hoonaard, B. ;
Ott, H. W. ;
Hofer, S. ;
Pluetschow, A. ;
Diehl, V. ;
Engert, A. ;
Borchmann, P. .
ANNALS OF ONCOLOGY, 2010, 21 (10) :2052-2060
[10]   Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis [J].
Ben-Aharon, Irit ;
Gafter-Gvili, Anat ;
Leibovici, Leonard ;
Stemmer, Salomon M. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) :803-811